Welcome to our dedicated page for Norris Inds SEC filings (Ticker: NRIS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Norris Inds's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Norris Inds's regulatory disclosures and financial reporting.
Norris Industries (NRIS) reported Q2 FY2026 results for the quarter ended August 31, 2025. Revenue was $84,388, up slightly from $77,007 a year ago, while the net loss widened to $151,889 from $117,856 as higher lease operating and G&A costs offset modest sales gains.
For the first six months, revenue was $177,158 versus $177,274 last year, with a net loss of $319,297. Management attributes expense pressure partly to plugging and abandoning four wells. Interest expense decreased as prior notes were converted to equity in November 2024.
Liquidity remains tight: cash was $40,323 and working capital was negative by about $75,000 as of August 31, 2025. Related‑party notes totaled $3.5 million, and the company had $700,000 available on its credit line, with a subsequent $100,000 draw after quarter‑end. Stockholders’ deficit was $(4.43) million. Internal disclosure controls and procedures were deemed not effective due to previously identified material weaknesses. As of September 15, 2025, 108,245,688 common shares were outstanding.
